Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $61.85 | $18.51 | 234.23% | 257.71x | 18.66x | 18.90x | 50.66x | 1.22x | $41.15M | 0.76% | $108.58M | 1.23 | $5.46B | 101.90 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $303.05 | $95.36 | 217.80% | 69.51x | 41.09x | 9.39x | 37.62x | 1.43x | $641.34M | 1.59% | $1.08B | 8.09 | $41.72B | 45.13 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $6.18 | $2.86 | 116.19% | 88.29x | 51.72x | 3.35x | 82.00x | 0.85x | $47.52M | 4.51% | $13.01M | 0.08 | $1.21B | 22.72 | ||
| CORT | CORCEPT THERAPEUTICS INC | $72.62 | $19.07 | 280.73% | 157.87x | 138.69x | 9.86x | 12.22x | 1.49x | $119.79M | 1.58% | $637.99M | 6.11 | $7.70B | -1,121.00 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $48.42 | $17.53 | 176.17% | 49.41x | 37.93x | 4.91x | 6.15x | 1.34x | $164.23M | 4.43% | $605.69M | 7.92 | $3.54B | 31.79 | ||
| KRYS | KRYSTAL BIOTECH INC | $301.00 | $96.82 | 210.87% | 38.84x | 37.23x | 21.13x | 6.95x | 1.84x | $237.38M | 2.69% | $1.28B | 43.59 | $8.38B | 39.17 | ||
| ADMA | ADMA BIOLOGICS INC | $7.97 | $10.61 | -24.90% | 11.55x | 8.03x | 3.69x | 4.73x | 0.39x | $107.90M | 5.73% | $390.33M | 1.65 | $1.91B | 8.61 | ||
| HALO | HALOZYME THERAPEUTICS INC | $71.53 | $71.37 | 0.22% | 24.17x | 8.64x | 5.60x | 38.63x | 0.44x | $667.65M | 7.90% | $219.64M | 1.86 | $10.32B | 16.54 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $56.77 | $41.33 | 37.35% | 40.55x | 14.29x | 3.37x | 1.77x | 0.57x | $767.06M | 7.02% | $6.21B | 32.27 | $9.33B | 19.34 | ||
| RPRX | ROYALTY PHARMA PLC | $55.87 | $40.37 | 38.40% | 29.25x | 10.48x | 10.00x | 3.24x | 0.63x | $2.34B | 9.59% | $9.94B | 22.75 | $40.54B | 34.85 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.61 | $16.46 | -35.54% | 5.18x | 22.58x | 5.07x | 3.05x | 0.65x | $56.42M | 9.10% | $205.80M | 3.52 | $532.76M | 3.68 | ||
| VCEL | VERICEL CORP | $36.30 | $9.25 | 292.52% | 84.42x | 75.30x | 6.31x | 5.20x | 1.78x | $47.49M | 2.58% | $356.23M | 7.02 | $1.84B | 45.50 | ||
| OMER | OMEROS CORP | $9.79 | $15.71 | -37.70% | 7.53x | -25.71x | 70.94x | -11.19x | 0.38x | -$94.78M | -13.46% | -$63.33M | -0.88 | $1.02B | 11.25 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $237.00 | $96.86 | 144.69% | 30.00x | 26.30x | 17.17x | 4.76x | 1.47x | $122.22M | 2.59% | $997.32M | 50.16 | $5.09B | 22.55 | ||
| ASND | ASCENDIS PHARMA A | $210.45 | $84.80 | 148.19% | 22.31x | 16.94x | 12.83x | 22.77x | 2.08x | $52.94M | 0.40% | $574.09M | 9.24 | $13.45B | 144.25 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $238.57 | $49.34 | 383.50% | 507.60x | 9.24x | 3.33x | 3.30x | 1.73x | $1.30B | 8.79% | $4.53B | 73.22 | $18.53B | 27.45 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.82 | $5.80 | -51.42% | 10.44x | 4.13x | 2.64x | 3.08x | 0.22x | $7.24M | 4.47% | $52.93M | 0.92 | $109.63M | 7.07 | ||
| TGTX | TG THERAPEUTICS INC | $40.16 | $18.85 | 113.08% | 12.47x | 26.76x | 8.28x | 10.54x | 8.16x | -$14.19M | -0.24% | $583.13M | 4.04 | $6.46B | 43.04 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $32.20 | $36.29 | -11.28% | 12.73x | 8.77x | 2.07x | 2.05x | 0.48x | $341.79M | 18.36% | $910.35M | 15.75 | $1.43B | 6.05 | ||
| TECH | BIO-TECHNE CORP | $51.99 | $15.57 | 233.82% | 73.23x | 26.44x | 6.71x | 3.90x | 1.50x | $269.60M | 3.32% | $2.09B | 13.34 | $8.22B | 32.11 | ||
| UTHR | UNITED THERAPEUTICS CORP | $549.87 | $250.37 | 119.63% | 18.78x | 18.92x | 7.55x | 3.96x | 1.99x | $1.02B | 4.25% | $5.90B | 135.66 | $22.06B | 12.87 | ||
| EXEL | EXELIXIS INC | $52.70 | $31.22 | 68.80% | 16.89x | 16.00x | 5.73x | 6.84x | 1.23x | $917.69M | 6.74% | $1.94B | 7.49 | $13.19B | 12.49 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.45 | $2.49 | 38.58% | 14.38x | 14.58x | 2.11x | 3.34x | 0.97x | $4.11M | 1.48% | $82.33M | 1.03 | $210.80M | 9.92 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.27 | $15.08 | 107.36% | 17.28x | 16.26x | 6.40x | 3.78x | 1.96x | $208.13M | 5.44% | $1.01B | 8.28 | $3.07B | 9.18 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $635.45 | $448.27 | 41.75% | 14.93x | 13.44x | 4.43x | 2.12x | 0.98x | $4.11B | 6.22% | $31.42B | 302.15 | $66.36B | 11.55 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.99 | $1.76 | 12.90% | 10.47x | 9.16x | 2.08x | 2.38x | 0.90x | $13.00M | 8.19% | $67.23M | 0.84 | $127.11M | 5.69 | ||
| VCYT | VERACYTE INC | $48.73 | $12.49 | 290.19% | 43.90x | 43.30x | 7.15x | 2.89x | 2.52x | $155.34M | 4.01% | $1.34B | 16.90 | $3.66B | 31.84 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $446.83 | $171.80 | 160.08% | 26.27x | 22.84x | 9.29x | 5.86x | 1.87x | $3.71B | 3.27% | $19.36B | 76.20 | $109.90B | 20.38 | ||
| INCY | INCYTE CORP | $102.38 | $66.95 | 52.92% | 14.04x | 13.00x | 3.81x | 3.64x | 1.24x | $1.45B | 7.11% | $5.62B | 28.21 | $17.02B | 9.10 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $15.75 | $4.66 | 238.23% | 26.25x | 4.52x | 0.76x | 1.10x | 3.68x | $109.24M | 6.60% | $1.51B | 14.34 | $2.24B | 27.02 | ||
| MDXG | MIMEDX GROUP INC | $3.74 | $1.58 | 136.62% | 17.81x | -52.38x | 1.43x | 2.29x | 2.76x | $69.36M | 12.49% | $242.94M | 1.64 | $414.88M | 7.62 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.